Trials Support Wavefront Lasik For Farsighted
Bausch & Lomb’s Zyoptix hyperopia study indicates good results with custom wavefront-guided Lasik, Visx already approved.
Original post by Glenn Hagele - USAEyes - glenn.hagele@usaeyes.org
Bausch & Lomb’s Zyoptix hyperopia study indicates good results with custom wavefront-guided Lasik, Visx already approved.
Original post by Glenn Hagele - USAEyes - glenn.hagele@usaeyes.org
A preliminary inspection of Bausch and Lomb’s Greenville SC manufacturing plant fails to find connection between the once popular contact lens solution and a recent outbreak of eye infections.
Original post by Glenn Hagele - USAEyes - glenn.hagele@usaeyes.org
A new study published in the April issue of the medical journal Ophthalmology indicates that patients with systemic diseases that are traditionally listed as relative or absolute contraindications may have Lasik safely and with predictable results.
Original post by Glenn Hagele - USAEyes - glenn.hagele@usaeyes.org
Nationwide Lasik doctor organization provides Lasik laser eye surgery for free to help quadriplegics gain greater independence.
Original post by Glenn Hagele - USAEyes - glenn.hagele@usaeyes.org
A controversial new study indicates that cosmetic procedures such as Botox and possibly Lasik may be valuable treatments for clinical depression.
Original post by Glenn Hagele - USAEyes - glenn.hagele@usaeyes.org
Designation will allow Medicare beneficiaries to select the advanced technology intraocular lens for an extra fee.
Original post by Glenn Hagele - USAEyes - glenn.hagele@usaeyes.org
Patient advocacy issues advisory about website advertises home kit for popular Lasik laser eye surgery.
Original post by Glenn Hagele - USAEyes - glenn.hagele@usaeyes.org
New modified Schwind ESIRIS excimer laser system determines progress of laser during surgery with constant measurement of corneal thickness to assure accurate results.
Original post by Glenn Hagele - USAEyes - glenn.hagele@usaeyes.org
In a public letter, Bausch & Lomb’s Chairman and CEO Ron Zarrella announces that the company has permanently withdrawn ReNu with MoistureLoc from the market, with no plans to renew production.
Original post by Glenn Hagele - USAEyes - glenn.hagele@usaeyes.org
In a public letter, Bausch & Lomb’s Chairman and CEO Ron Zarrella announces that the company has permanently withdrawn ReNu with MoistureLoc from the market, with no plans to renew production.
Original post by Glenn Hagele - USAEyes - glenn.hagele@usaeyes.org